Dr. Mahmoud B. Morsi

Dr. Levy is a Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami. She was awarded the Arthur Hertz Endowed Chair in Liver Diseases. Dr. Levys clinical research program focuses on autoimmune and cholestatic liver diseases, and in the study of porphyrias. She is particularly interested in clinical trial development and conduct. Dr. Levy is a member of the steering committees for the International Primary Sclerosing Cholangitis Study group (IPSCSG), the Global PBC study group and the Cholestatic and Autoimmune Liver Diseases SIG in AASLD and serves as an advisor for several patient support groups and foundations. She is currently the chair elect for the AASLD Practice Guidelines Committee. Dr Levys expertise is recognized internationally. Dr. Levy received her M.D. from Universidade Federal do Rio de Janeiro (UFRJ). She completed house staff training both at her home University and subsequently at University of Miami/Jackson Memorial Hospital, in Miami, FL. Dr. Levy completed her 3-year Gastroenterology Fellowship at Mayo Clinic in Rochester, Minnesota, and a 1-year Transplant Hepatology Fellowship at University of Florida, in Gainesville, FL. Dr. Levy is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Primary Biliary Cholangitis, Cholangitis, Sclerosing Cholangitis, Liver Transplant, and Kidney Transplant. Dr. Levy is currently accepting new patients.

Antonio Pinna is a Transplant Surgeon practicing medicine in Weston, Florida. Dr. Pinna is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Liver Failure, Liver Cancer, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Pinna is currently accepting new patients.

Dr. Lekakis is a Professor of Medicine who joined the University of Miami in 2010 and became an attending physician for Hemotology/Oncology and Blood and Marrow Transplantation in 2012. He has since started the CAR-T trials, performed the first CAR-T for solid tumors, and transplanted adult sickle cell disease patients. Dr. Lekakis is a member of the USA CAR-T Consortium and several CIBMTR committees including CAR-T, Lymphoma, Leukemia, and GVHD. His main interests are CAR-T and GVHD. Dr. Lekakis is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft. Dr. Lekakis is currently accepting new patients.